CA
ATRA icon

Cliff Asness’s Atara Biotherapeutics ATRA Stock Holding History

Cliff Asness’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,079
Closed -$128K – 2764
2024
Q2 		$128K Sell
15,079
-89,940
-86% -$1.35M ﹤0.01% 2474
2024
Q1 		$1.82M Sell
105,019
-12,273
-10% -$218K ﹤0.01% 1458
2023
Q4 		$1.5M Buy
117,292
+83,514
+247% +$1.95M ﹤0.01% 1460
2023
Q3 		$1.25M Buy
33,778
+27,087
+405% +$1.21M ﹤0.01% 1522
2023
Q2 		$269K Buy
6,691
+4,652
+228% +$263K ﹤0.01% 1980
2023
Q1 		$148K Sell
2,039
-3,389
-62% -$329K ﹤0.01% 2091
2022
Q4 		$445K Sell
5,428
-14,979
-73% -$1.56M ﹤0.01% 1852
2022
Q3 		$1.93M Buy
+20,407
New +$2.29M ﹤0.01% 1218
2022
Q2 		– Sell
-1,336
Closed -$310K – 2183
2022
Q1 		$310K Buy
+1,336
New +$425K ﹤0.01% 1956
2021
Q3 		– Sell
-1,062
Closed -$413K – 2243
2021
Q2 		$413K Sell
1,062
-785
-43% -$280K ﹤0.01% 1957
2021
Q1 		$663K Buy
1,847
+995
+117% +$440K ﹤0.01% 1729
2020
Q4 		$418K Buy
+852
New +$393K ﹤0.01% 1844
2019
Q4 		– Sell
-451
Closed -$159K – 2115
2019
Q3 		$159K Buy
+451
New +$168K ﹤0.01% 2044
2019
Q2 		– Sell
-412
Closed -$409K – 2068
2019
Q1 		$409K Sell
412
-428
-51% -$398K ﹤0.01% 1870
2018
Q4 		$729K Sell
840
-24
-3% -$22.3K ﹤0.01% 1631
2018
Q3 		$894K Buy
864
+97
+13% +$94.8K ﹤0.01% 1743
2018
Q2 		$704K Buy
767
+473
+161% +$508K ﹤0.01% 1862
2018
Q1 		$286K Buy
+294
New +$268K ﹤0.01% 2054

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cliff Asness's ATRA Position: Q3 2024 in Review

Cliff Asness sold out of Atara Biotherapeutics (ATRA) in Q3 2024, closing a stake of 15,079 shares — an estimated $128K sold.

Cliff Asness first reported a position in ATRA in Q1 2018 and held it in 18 quarters. The position peaked at $1.93M in Q3 2022. 35 funds tracked by Wall St. Rank hold ATRA as of Q3 2024.

  • Cliff Asness reported no remaining Atara Biotherapeutics position as of Q3 2024 after selling out during the quarter.
  • Cliff Asness sold 15,079 Atara Biotherapeutics shares in Q3 2024, an estimated $128K.
  • Cliff Asness first reported a position in Atara Biotherapeutics in Q1 2018 and held it in 18 quarters.
  • Cliff Asness's Atara Biotherapeutics position peaked at $1.93M in Q3 2022.
  • 35 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2024.

Based on AQR Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.